Details of the Drug

General Information of Drug (ID: DMBE5OK)

Drug Name

AZD7798

Indication

Disease Entry	ICD 11	Status	REF
Crohn disease	DD70	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05452304) A Phase 1 Randomised, Double-Blind, Placebo-Controlled 3 Part Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7798 Following Single Ascending Dose Administration and Repeat Dose Administration in Healthy Subjects (Including Japanese and Chinese Subjects), and Patients With Crohn's Disease. U.S.National Institutes of Health.